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Objective: To examine ethnic differences in ectopic fat and associations with incident diabetes.
Methods: In a UK cohort study, 1338 Europeans, 838 South Asians, and 330 African Caribbeans living in
London were aged 40-69 years at baseline. Baseline assessment included blood tests, anthropometry,
and questionnaires. Anthropometry-based prediction equations estimated baseline visceral adipose tissue
(VAT). Incident diabetes was ascertained from record review, self-report, or oral glucose tolerance testing.
Results: South Asians had more and African Caribbeans less estimated VAT than Europeans. Both ethnic
minorities had larger truncal skinfolds than Europeans. In men, adjustment for risk factors (BMI, smoking, sys-
tolic blood pressure, and HDL-cholesterol) markedly attenuated the association between estimated VATand
diabetes in Europeans (standardized subhazard ratios [95% CI]: from 1.74 [1.49, 2.03] to 1.16 [0.77, 1.76])
and African Caribbeans (1.72 [1.26, 2.35] to 1.44 [0.69, 3.02]) but not South Asians (1.60 [1.38, 1.86] to 1.90
[1.37, 2.64]). In women, attenuation was observed only for South Asians (1.80 [1.01, 3.23] to 1.07 [0.49, 2.31]).
Associations between truncal skinfolds and diabetes appeared less affected by multivariable adjustment in
South Asians and African Caribbeans than Europeans (1.24 [0.97, 1.57] and 1.28 [0.89, 1.82] versus 1.02
[0.77, 1.36] in men; 1.91 [1.03, 3.56] and 1.42 [0.86, 2.34] versus 1.23 [0.74, 2.05] in women).
Conclusions: Differences in overall truncal fat, as well as VAT, may contribute to the excess of diabetes
in South Asian and African Caribbean groups, particularly for women.
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Introduction
Burgeoning levels of obesity have led to a marked global rise in type
2 diabetes (1). Central obesity, in particular abdominal visceral adi-
pose tissue (VAT), is thought to contribute to diabetes risk beyond
general adiposity (2). Other ectopic fat depots may also increase dia-
betes risk, while abdominal and lower body subcutaneous adipose tis-
sue (SAT) appears to be metabolically protective (3-5).
Migrant populations of South Asian and African Caribbean descent
are at greater risk of type 2 diabetes than those of European descent,
and this may relate to ethnic differences in body composition (4,6).
In most studies, South Asians have more VAT than Europeans (7,8),
whereas African Caribbeans have less (9,10); therefore abdominal
obesity is an unlikely explanation for the excess diabetes seen in the
latter group. We have previously identified truncal skinfold thick-
ness as an independent risk factor for diabetes in South Asians and
African Caribbeans (4), but it is unclear how this compares with
VAT or SAT. Additionally, whilst lower body adiposity may have a
favorable relationship with metabolic risk factors in Europeans (5),
there is little research examining its influence in South Asians.
Many studies report longitudinal associations between waist circum-
ference, waist/hip ratio, or BMI and incident diabetes (11). Few pro-
spective studies have examined the impact of VAT and SAT on
incident diabetes (12-15), and none that we are aware of have pre-
sented ethnic differences or included South Asians.
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Using data from a community-based follow-up study, we assessed
ethnic differences in estimated VAT, estimated SAT, and measures
of overall truncal and lower body adiposity. Furthermore, we exam-
ined associations between baseline adiposity measures and incident
diabetes, alone and in combination, by ethnicity.
Methods
Ethics statement
Participants gave written informed consent. Approval for the base-
line study was obtained from Ealing, Hounslow and Spelthorne,
Parkside, and University College London research ethics commit-
tees, and at follow-up from St. Mary’s Hospital Local Research
Ethics Committee (reference 07/HO712/109).
Study sample
The SABRE study is a multiethnic cohort study of cardiometabolic
disease; with details published elsewhere (16). Participants aged 40-
69 years at baseline (1988-1991) were randomly selected from age-
and sex-stratified primary care physician lists (n5 4063) and work-
places (n5 795) in north-west London. From this point, the terms
“European,” “South Asian,” and “African Caribbean” refer to partici-
pants from those ethnic groups living in London. South Asian and
African Caribbean participants were first-generation migrants—South
Asians from the Indian subcontinent, (52% were of Punjabi Sikh ori-
gin) and African Caribbeans from the Caribbean (93%) or West
Africa. Participants were followed up between 2008 and 2011, aged
58 to 85 years (n5 4196). The diabetes status of 2533 individuals
was available at follow-up (Figure S1, Supporting Information), and
1410 of these attended a research clinic at follow-up. A male prepon-
derance in the data exists in South Asians and Europeans as the base-
line study was initially designed to examine cardiometabolic disease
in men, but the distribution of men and women was more equal for
African Caribbeans, who were recruited later into the study.
Baseline measurements
Participants underwent fasting blood tests, blood pressure measure-
ment and anthropometry, and completed a health and lifestyle
questionnaire. Truncal skinfolds comprised the sum of sub-scapular
and supra-iliac skinfolds, and leg skinfolds the sum of thigh and
supra-patellar skinfolds. Anthropometry was measured by four
trained observers, one acted as the standard and periodic standardi-
zation measurements were made during the study to ensure good
interobserver reliability. Those whose diabetes status was unknown
underwent oral glucose tolerance testing (OGTT). HOMA2-IR (17)
and the Matsuda index (18) were used to quantify insulin resist-
ance. Physician diagnosis (from self-report or record review) or
World Health Organization 1999 criteria (19) for fasting and
OGTT blood glucose measurements defined baseline diabetes.
Physical activity comprised the total weekly energy expended (MJ)
on sports, walking and daily activities, using questions based on
the Allied Dunbar fitness survey (20) and energy expenditure esti-
mates (21).
Follow-up measurements
During 2008-2011, survivors participated in follow-up, including a
health questionnaire, primary care medical record review, and/or
attendance at clinic at St. Mary’s hospital, London, where blood
tests and anthropometry were performed. Additionally, VAT and
SAT were measured by abdominal computer tomography (CT) scan
at 125kVwith a Philips MX 8000 IDT64 detector, as previously
described (7).
Estimation of baseline abdominal visceral and
SAT
In a previously published analysis of our follow-up data, we derived
and rigorously evaluated prediction equations of CT-measured VAT
and SAT by sex and ethnic group, using age and anthropometric
measures (7). Equations took the following form:
VAT (or SAT)5 b01 (b1 3 age)1 (b2 3 weight)1 (b3 3
height)1 (b4 3 waist circumference)1 (b5 3 hip circum-
ference)1 (b6 3 thigh circumference)
Full equations are provided in Supporting Information Table S1. To
estimate baseline VAT and SAT, we applied the appropriate sex-
and ethnic-specific prediction equation to baseline anthropometric
data.
Identification of incident diabetes
Incident diabetes was identified from one of the following direct
sources: primary care medical record review (recorded diagnosis of
diabetes or prescription of antidiabetic medications), participant
questionnaire (recall of physician-diagnosed diabetes plus either year
of diagnosis or receipt of named antidiabetic medication), or follow-
up at 20 years [fasting or OGTT plasma glucose results meeting
World Health Organization 1999 criteria (19)]. Participants were
also indirectly followed-up for diabetes, using death certificate data
(diabetes listed as an underlying cause of death: ICD9 codes: 2500-
2509, ICD 10 codes: E100-E149).
Statistical analyses
Baseline characteristics were examined by follow-up status then
compared between ethnic groups, stratified by sex and adjusted for
age, using ANOVA or logistic regression models, as appropriate.
Correlations between adiposity measures were inspected using
Pearson’s correlation coefficients, and ethnic differences tested for
using Fisher’s z transform test (22). We examined associations
between depot-specific abdominal adiposity (estimated VAT and
SAT), truncal skinfolds (as a validated marker of truncal subcuta-
neous fat), and leg skinfolds (as a marker of lower body subcutane-
ous fat) and diabetes, rather than general measures of adiposity, to
elucidate the explicit effects of these variables and their inter-
relationships. Informative censoring may have occurred due to
death from causes other than diabetes; we addressed this by using
competing risks regression (competing risk5 death from nondiabe-
tes cause), based on Fine and Grey proportional subhazards meth-
ods (23).
When assessing associations between estimated VAT or SAT and
diabetes, we attempted to incorporate the uncertainty in the coeffi-
cients of the prediction equations used to obtain baseline estimated
VAT and SAT values. Firstly, using follow-up data, we employed
Bayesian linear regression models to estimate b-coefficients for the
VAT and SAT prediction equations. Then the uncertainty in these
estimates was propagated to the estimation of VAT and SAT at
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baseline. Finally, Monte-Carlo simulation (24) was used to perform
the competing risk regressions evaluating the effect of estimated
baseline VAT and SAT, adjusted for age, on incident diabetes,
accounting for the uncertainty in baseline estimated SAT and VAT.
Convergence was assessed using Gelman-Rubin diagnostics (24),
and estimates based on 1500 samples after convergence.
We considered each adiposity measure in turn, and compared estimates
adjusted for age (model 1) with those adjusted for age and BMI (model
2) to establish whether associations were independent of overall body
size. Subsequently, we adjusted model 2 (adiposity measur-
e1 age1BMI) for the baseline cardiometabolic risk factors most asso-
ciated with incident diabetes (smoking status, systolic blood pressure,
and HDL-cholesterol), to establish whether associations were independ-
ent of these potential confounders (model 3). Following this, model 2
(adiposity measure1 age1BMI) was then adjusted for baseline insulin
resistance (measured by HOMA2-IR) (model 4), the Matsuda index,
fasting glucose and fasting insulin (data not shown for latter 3 models)
in turn. These analyses investigated potential mediating effects of insu-
lin resistance on associations between adiposity and diabetes.
Following this, we studied age-adjusted competing risks models con-
taining all body composition measures to examine their independent
effects on diabetes, by sex, and ethnicity. Collinearity was assessed
using variance inflation factors (VIFs), with a (VIF) >10.0 indicat-
ing model instability (25).
Interactions between the effects of ethnicity or sex and each body
composition variable on diabetes were sought in all models. We
examined Nelson-Aalen cumulative hazard plots by tertile of body
composition variables to check for violations of the proportional
hazards assumption; none were found. To test for bias due to case
ascertainment method, we used logistic regression models to deter-
mine associations between body composition variables and diabetes
where the date of diabetes diagnosis was unknown. Lastly, we fur-
ther adjusted the maximally adjusted competing risks models for
baseline heart rate and physical activity, as proxies for physical fit-
ness. Analyses were performed in Stata 12 (College Station, Texas),
using a statistical significance level of P< 0.05.
Results
At baseline, 4202 individuals did not have diabetes, of whom 3908
(93%) were traced at follow-up to a UK address (Figure S1, Sup-
porting Information). A total of 1338 (65%) Europeans, 838 (64%)
South Asians, and 330 (61%) African Caribbeans had follow-up
data and baseline body composition measurements available. With
the exception of leg skinfolds, which were greater in those without
follow-up data, baseline anthropometry, ethnicity, and metabolic
parameters did not differ in participants with and without follow-up
data (Table S2, Supporting Information). Over a median 19 years
follow-up, incident type 2 diabetes was higher in South Asians and
African Caribbeans than Europeans [34% (n5 281, P< 0.001) and
29% (n5 96, P< 0.001) vs. 14% (n5 191)].
South Asian men but not women had greater baseline estimated
abdominal VAT than Europeans (Table 1). However, South Asian
women had greater estimated abdominal SAT and leg skinfolds than
European women, in contrast to men where there was no ethnic dif-
ference. Of note, South Asians of both sexes had larger truncal skin-
folds than Europeans. African Caribbean men and women had less
estimated VAT and smaller leg skinfolds than Europeans (Table 1).
African Caribbean men had less, and women more, estimated SAT
then Europeans. Truncal skinfolds were also larger in African Carib-
bean men and women, when compared with Europeans. Men and
women of South Asian and African Caribbean origin generally had
adverse blood pressure, lipid, glycemic, and insulin resistance pro-
files, compared with Europeans (Table 1).
Estimated VAT was highly correlated with estimated SAT in univariate
analyses, but less so with leg skinfolds (Table S3, Supporting Informa-
tion). There were no consistent ethnic differences in correlations. In
general, higher adiposity measures were adversely associated with inci-
dent diabetes in age-adjusted models (Table 2). There were no statisti-
cally significant sex or ethnic differences in the effects of adiposity
measures. In these models, the measures most associated with incident
diabetes were estimated SAT in European and African Caribbean men,
estimated VAT in South Asian men, European women and African
Caribbean women, and truncal skinfolds in South Asian women. Addi-
tionally, we studied age-adjusted models where uncertainty in the VAT
and SAT prediction equations had been accounted for within a Bayes-
ian framework. These showed estimates with similar directions, magni-
tudes, margins of uncertainty, and interethnic patterns as the main uni-
variate models (Figures S2 and S3, Supporting Information).
We inspected models of age and BMI-adjusted associations between
each adiposity measure and diabetes (Table 2). This base model was
then further adjusted for cardiometabolic risk factors and insulin
resistance in turn. In European men, estimated VAT was the only
measure to retain a strong association with diabetes after BMI adjust-
ment; this was attenuated by adjustment for cardiometabolic risk fac-
tors and, to a lesser extent, for insulin resistance. In South Asian men,
associations between estimated VAT and diabetes increased after
adjustment for BMI, and remained (although reduced) when further
adjusted for cardiometabolic risk factors and insulin resistance. Colli-
nearity diagnostics showed a VIF of >10 for estimated SAT and BMI
in South Asian men, so these results should be interpreted with cau-
tion. BMI-adjusted associations between estimated VAT and diabetes
appeared stronger in South Asian than European men [subhazard
ratios (SHR): 2.18, (95% CI;1.61, 2.96), versus 1.43 (1.00,2.05)],
although this was not significant as an interaction (P5 0.47). After
BMI adjustment, nonsignificant adverse associations with diabetes
persisted for estimated VAT and for truncal skinfolds in African
Caribbean men [SHRs (95% CI):1.38 (0.71, 2.66), P5 0.34 and 1.36,
(0.96, 1.86), P5 0.08, respectively]. Additionally, there appeared to
be a weak protective association for leg skinfolds; none of these asso-
ciations were greatly affected by further adjustment.
In European women, strong associations persisted for estimated
VAT after BMI adjustment, which were diminished in the insulin
resistance model. Truncal skinfolds were still associated with diabe-
tes independent of BMI in South Asian women, and neither cardio-
metabolic risk factors nor insulin resistance could account for the
association with diabetes. In African Caribbean women, associations
persisted for estimated VAT and truncal skinfolds independent of
BMI; after accounting for cardiometabolic risk factors or insulin
resistance, these associations remained largely unaltered.
We examined multivariable models of all adiposity measures of interest
in combination (estimated VAT and SAT, truncal, and leg skinfolds; Fig-
ures 1 and 2). Only estimated VAT retained independent associations
with diabetes in European and South Asian men, whilst in African
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Caribbean men, detrimental associations persisted only for truncal skin-
folds, and leg skinfolds appeared to be protectively associated. Associa-
tions between estimated VAT and diabetes were greater in South Asian
then European men [SHR: 2.09, (95% CI; 1.45, 3.03) vs. 1.52 (1.02,
2.30)], but again this was not significant as an interaction (P5 0.76). In
European and African Caribbean women, estimated VAT remained
TABLE 1 Baseline characteristics: SABRE study
Variable Europeans South Asians Pa African Caribbeans Pa
In men without diabetes
n 1043 702 - 185 -
Age (years) 526 7 516 7 <0.0001 536 6 0.08
Estimated VAT (cm2) 1276 74 1616 67 <0.0001 1136 66 0.001
Estimated SAT (cm2) 1966 62 1936 63 0.22 1486 67 <0.0001
Truncal skinfolds (mm) 396 14 476 14 <0.0001 436 18 0.003
Leg skinfolds (mm) 226 8 226 8 0.71 196 7 <0.0001
Waist circumference (cm) 916 10 926 10 0.01 896 10 0.001
BMI (kg/m2) 266 4 256 3 0.03 266 3 0.46
Ever smoked (%) 72 26 <0.001 44 <0.001
Heart rate (beats/min) 656 11 676 10 <0.0001 636 10 0.02
Physical activity (MJ/wk) 11 (7-16) 10 (6-13) <0.0001 10(7-15) 0.17
Systolic BP (mmHg) 1216 16 1246 17 0.001 1276 15 <0.0001
HDL (mmol/l) 1.36 0.3 1.26 0.3 <0.0001 1.56 0.4 <0.0001
Fasting glucose (mmol/l) 5.46 0.6 5.56 0.6 <0.0001 5.56 0.6 0.02
Postload glucose (mmol/l) 5.06 1.3 5.46 1.5 <0.0001 5.86 1.6 <0.0001
Fasting insulin (pmol/l) 7(5-11) 10 (7-14) <0.0001 8 (5-11) 0.31
Postload insulin (pmol/l) 20 (12-33) 40 (23-73) <0.0001 25 (16-40) 0.001
HbA1c (%) 5.5 (5.3-5.7) 5.7(5.5-6.0) <0.0001 5.8 (5.5-6.0) <0.0001
HbA1c (mmol/mol) 37 (34-39) 39(37-42) <0.0001 40 (37-42) <0.0001
HOMA2-IR 0.8 (0.6-1.2) 1.1(0.8-1.6) <0.0001 1.0 (0.6-1.3) 0.14
Matsuda index 0.11 (0.07-0.17) 0.18 (0.12-0.30) <0.0001 0.14 (0.09-0.21) 0.0004
In women without diabetes
n 295 136 - 145 -
Age (years) 536 7 506 6 <0.0001 526 6 0.49
Estimated VAT (cm2) 856 57 866 46 0.35 776 50 0.36
Estimated SAT (cm2) 2486 88 3236 80 <0.0001 2946 113 <0.0001
Truncal skinfolds (mm) 406 19 676 15 <0.0001 536 20 <0.0001
Leg skinfolds (mm) 536 19 676 16 <0.0001 486 18 0.09
BMI (kg/m2) 266 5 276 4 0.02 296 5 <0.0001
Waist circumference (cm) 796 12 846 10 0.0001 886 12 <0.0001
Ever smoked (%) 52 3 <0.001 19 <0.001
Heart rate (beats/min) 656 9 706 11 <0.0001 646 11 0.14
Physical activity (MJ/wk) 8 (5-13) 6 (1-10) <0.0001 10 (7-13) 0.02
Systolic BP (mmHg) 1196 17 1236 22 <0.0001 1296 16 <0.0001
HDL (mmol/l) 1.76 0.5 1.46 0.3 <0.0001 1.76 0.4 0.86
Fasting glucose (mmol/l) 5.36 0.5 5.06 0.5 <0.0001 5.46 0.6 0.05
Postload glucose (mmol/l) 5.86 1.4 5.76 1.2 0.55 6.56 1.5 <0.0001
Fasting insulin (pmol/l) 5 (4-8) 7 (5-10) <0.0001 10 (6-13) <0.0001
Postload insulin (pmol/l) 22 (15-35) 44 (26-67) <0.0001 36 (24-57) <0.0001
HbA1c (%) 5.4 (5.2-5.7) 5.7 (5.4-6.0) 0.0001 5.7 (5.4-6.2) 0.26
HbA1c (mmol/mol) 36 (33-39) 39 (36-42) 0.0001 39 (36-424) 0.26
HOMA2-IR 0.6 (0.4-0.9) 0.8 (0.6-1.1) 0.002 1.1 (0.7-1.4) <0.0001
Matsuda index 0.10 (0.07, 0.16) 0.17 (0.10-0.24) <0.0001 0.19 (0.13-0.29) <0.0001
Data are mean6SD or median (IQR) unless otherwise indicated.
aAge-adjusted P for ethnic difference, when compared with Europeans.
VAT: visceral adipose tissue; SAT: subcutaneous adipose tissue; truncal skinfolds: subscapular skinfold 1 suprailiac skinfold; leg skinfolds: thigh skinfold 1 suprapatellar
skinfold; BP: blood pressure.
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adversely associated with diabetes, and truncal skinfolds were also
unfavorably associated in the latter group. In South Asian women, only
truncal skinfolds appeared independently associated, albeit nonsignifi-
cantly (SHR: 1.74, 95% CI: 0.84, 3.62, P5 0.14). Patterns of associa-
tions were identical when these models were further adjusted for BMI.
With the exception of the BMI-adjusted SAT models for South Asian
men, collinearity was within acceptable limits for all models. When
multivariable models were adjusted for the Matsuda index, fasting
glucose and fasting insulin, results were similar in all cases to those
seen with adjustment for HOMA2-IR, though the latter metric had the
most consistent impact on the associations between adiposity and dia-
betes. No statistically significant interactions between sex or ethnicity
and adiposity measures were observed in multivariable models. Anal-
yses including individuals with no date of diabetes diagnosis produced
identical patterns to the main analyses, as did those adjusting for
baseline heart rate and physical activity levels (data not shown).
Discussion
There were distinct patterns of fat distribution by ethnicity: South
Asians and African Caribbeans had larger truncal skinfolds than
TABLE 2 Multivariable associations between adiposity measures and incident diabetes: SABRE study
Adiposity measure Model
Europeans South Asians African Caribbeans
SHR 95% CI SHR 95% CI SHR 95% CI
In men
VAT 1 1.74*** 1.49, 2.03 1.60*** 1.38, 1.86 1.72** 1.26, 2.35
2 1.43* 1.00, 2.05 2.18*** 1.61, 2.96 1.38 0.71, 2.66
3 1.16 0.77, 1.76 1.90*** 1.37, 2.64 1.44 0.69, 3.02
4 1.32 0.90, 1.94 1.87*** 1.36, 2.55 1.35 0.70, 2.62
SAT 1 2.05*** 1.67, 2.52 1.59*** 1.36, 1.87 1.74** 1.23, 2.46
2 1.22 0.51, 2.93 2.81** 1.46, 5.42 1.03 0.39, 2.64
3 0.74 0.27, 2.04 2.67** 1.37, 5.23 1.25 0.48, 3.22
4 0.84 0.35, 2.03 2.21* 1.11, 4.37 1.04 0.41, 2.68
Truncal skinfolds 1 1.73*** 1.46, 2.07 1.49*** 1.29, 1.72 1.57*** 1.24, 1.98
2 1.21 0.94, 1.56 1.21 0.99, 1.49 1.34 0.96, 1.86
3 1.02 0.77, 1.36 1.24 0.97, 1.57 1.28 0.89, 1.86
4 1.11 0.86, 1.43 1.07 0.86, 1.33 1.27 0.89, 1.82
Leg skinfolds 1 1.87*** 1.38, 2.54 1.60** 1.22, 2.11 1.13 0.54, 2.37
2 1.06 0.71, 1.59 1.03 0.73, 1.47 0.42 0.15, 1.22
3 1.00 0.62, 1.60 1.08 0.72, 1.62 0.49 0.17. 1.41
4 1.04 0.68, 1.58 0.87 0.61, 1.25 0.41 0.13, 1.19
In women
VAT 1 2.35*** 1.74, 3.19 1.80* 1.01, 3.23 2.85*** 1.84, 4.41
2 2.66* 1.14, 6.20 1.24 0.59, 2.58 3.36** 1.50, 7.53
3 2.71* 1.16, 6.34 1.07 0.49, 2.31 3.18** 1.37, 7.39
4 2.39 0.97, 5.89 0.96 0.45, 2.04 3.32* 1.21, 9.11
SAT 1 1.70*** 1.37, 2.12 1.44 0.98, 2.12 1.29* 1.05, 1.59
2 1.08 0.48, 2.46 0.82 0.26, 2.60 0.79 0.44, 1.43
3 0.93 0.44, 1.96 0.94 0.29, 3.07 0.84 0.47, 1.51
4 1.09 0.55, 2.18 0.90 0.28, 2.89 0.83 0.44, 1.56
Truncal skinfolds 1 1.82*** 1.38, 2.38 2.00** 1.27, 3.13 1.70*** 1.29, 2.23
2 1.43 0.93, 2.20 1.91* 1.05, 3.48 1.65* 1.07, 2.54
3 1.23 0.74, 2.05 1.91* 1.03, 3.56 1.42 0.86, 2.34
4 1.37 0.89, 2.11 1.93* 1.05, 3.55 1.44 0.89, 2.32
Leg skinfolds 1 1.68** 1.15, 2.44 1.59* 1.04, 2.43 1.39 0.98, 1.97
2 1.19 0.80, 1.77 1.36 0.76, 2.43 1.07 0.59, 1.95
3 1.07 0.69, 1.65 1.41 0.80, 2.45 1.19 0.64, 2.19
4 1.23 0.84, 1.82 1.38 0.79, 2.43 1.20 0.64, 2.27
SHR: subhazard ratio (competing risks models) showing the effect of a 1 SD increase in each adiposity measure on incident diabetes.
*P< 0.05, ** P< 0.01, *** P< 0.001.
Model 1: adjusted for age, model 2: adjusted for age1BMI, model 3: adjusted for age1BMI1 smoking status1 systolic blood pressure1HDL-cholesterol, model 4:
adjusted for age1BMI1HOMA2-IR.
VAT: visceral adipose tissue; SAT: subcutaneous adipose tissue.
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Europeans. South Asian men had more estimated VAT than Euro-
peans, while African Caribbeans of both sexes had less. Accounting
for BMI, truncal adiposity was most strongly associated with diabe-
tes in South Asian women, whereas estimated VAT was most
strongly associated for all other groups. Associations between esti-
mated VAT and diabetes appeared stronger in South Asian than
European men, and in women than men of all ethnic groups. Adjust-
ment for insulin resistance attenuated associations between all fat
depots and diabetes in European men; patterns were not consistent
in the other groups, with the exception of South Asian men, in
whom the effects were retained.
Our findings of greater estimated VAT in South Asians than Euro-
peans match previous studies (8). Furthermore, comparisons of
South Asian and European children show that by early childhood,
South Asians have greater truncal fat deposition (26), persisting into
adulthood (27). This may arise due to a hyperinsulinemic in utero
environment, micronutrient deficiencies, or genetic differences (26).
Little data exist comparing lower body adiposity in these groups;
however, a recent study showed larger leg skinfolds in South Asians
than in Europeans (28), which we found only in women. Previous
studies comparing African and European origin populations have
also shown less VAT and larger truncal skinfolds in the African ori-
gin groups (9,10,29). Studies comparing leg adiposity in these ethnic
groups show inconsistent results (30,31).
The independent associations between estimated VAT and incident
diabetes we found in Europeans, South Asian men, and African
Caribbean women reflect previous findings (12-15). Our results sug-
gest the influence of VAT on the development of diabetes may be
greater in South Asian than European men. Although we are not
aware of any longitudinal studies comparing the effects of VAT in
these ethnic groups, cross-sectional work relating VAT to insulin
resistance hints this may be the case (8). Thus the excess diabetes
risk in South Asian men may be explained by both their greater
amount of VAT and its more adverse effects. Explanations for the
more deleterious role of VAT in South Asian than European men
may relate to differences in adipocyte morphology (32). There was
also a indication of a greater association between estimated VAT
and diabetes in women than men, reflecting findings from one longi-
tudinal study (14), but not others (12,13,15); explanations are
unclear.
We are not aware of any longitudinal studies showing that truncal
skinfolds are better associated with diabetes than VAT, as we found
in South Asian women, though as far as we know, no study has
examined these measures in combination (12-15). However, cross-
sectional studies have implied this: in a comparison of VAT, SAT
and truncal skinfolds, Abate et al. found that truncal skinfolds were
most strongly related to insulin sensitivity (33). A possible explana-
tion is that a higher proportion of circulating FFA, including those
reaching the liver, are released from upper body subcutaneous rather
than VAT (34). However, when there is relatively greater deposition
of VAT than SAT, its role in hepatic insulin resistance may
increase, although upper body SAT remains important in driving
peripheral insulin resistance (35).
The balance of subcutaneous and visceral fat varies with ethnicity—
the higher levels of estimated VAT and overall truncal subcutaneous
fat seen in South Asians when compared with Europeans may point
to a propensity for both central (VAT-mediated) and peripheral
(SAT-mediated) insulin resistance. However, the higher levels of
truncal subcutaneous fat seen in African Caribbeans suggest a tend-
ency toward peripheral insulin resistance, which may contribute to
their excess diabetes risk in the absence of high levels of estimated
VAT. Yet in general, baseline differences in insulin resistance did
not fully explain associations between either fat depot and diabetes
in this study. This may be due to imprecision in our estimates of
insulin resistance. Alternatively, the interplay between adiposity,
insulin resistance, and subsequent diabetes may be moderated by
factors which we were unable to explore, for example,
inflammation.
In our age-adjusted analyses, estimated SAT and leg skinfolds
appeared to be adversely associated with diabetes, probably as a
marker of overall adiposity, since these associations were attenuated
Figure 2 Multivariable associations between adiposity measures considered in com-
bination and incident diabetes in women: SABRE study. SHR5 subhazard ratio
(competing risks models) showing the effect of a 1 SD increase in each adiposity
measure on incident diabetes; lines indicate 95% confidence intervals (CI). Model
factors comprised age, estimated VAT, estimated SAT, truncal skinfolds and leg
skinfolds. SAT: subcutaneous adipose tissue; VAT: visceral adipose tissue.
Figure 1 Multivariable associations between adiposity measures considered in com-
bination and incident diabetes in men: SABRE study. SHR: subhazard ratio (com-
peting risks models) showing the effect of a 1 SD increase in each adiposity
measure on incident diabetes; lines indicate 95% confidence intervals (CI). Model
factors comprised age, estimated VAT, estimated SAT, truncal skinfolds, and leg
skinfolds. SAT: subcutaneous adipose tissue; VAT: visceral adipose tissue.
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or reversed in most groups once other fat depots were accounted
for, as others have shown (5). Few studies report longitudinal associ-
ations between lower body adiposity and diabetes (and none that we
know of by ethnicity), and those that do present contradictory results
(36,37). The effects of leg adipose tissue may vary with ethnicity,
and this is why we only found it to be negatively associated in Afri-
can Caribbean men.
This study is novel in presenting longitudinal associations between
specific fat depots and diabetes in three ethnic groups, and is the
first such study in South Asians that we know of. Other strengths
include a comparatively large sample size (12-15) and the focus on
four adiposity measures, allowing a more nuanced picture of the
interplay between upper and lower body adiposity (12-15). As with
any cohort study, loss to follow-up may have introduced bias,
though reasonable proportions of those traced were followed-up
(61-65%), and an analysis comparing responders and nonrespond-
ers found no consistent differences in baseline cardiometabolic or
adiposity variables. The latter finding implies follow-up data was
missing at random, and thus the observed attrition rates are
unlikely to introduce bias (38). Coupled with our use of random
sampling of the study population at baseline, this suggests our
findings may be generalizable to mid- to late-life populations of
these three ethnic groups resident in the UK, although in some
groups, numbers were small and thus the estimates presented in
multivariable models have wide margins of uncertainty. The use of
prediction equations to approximate baseline VAT and SAT will
have resulted in a less precise estimate of these depots than direct
measurement from CT or magnetic resonance (MR) imaging. How-
ever, the widespread use of CT or MR techniques for quantifying
fat depots is a recent phenomenon, and thus no long term cohorts
have employed these techniques. Furthermore, when longitudinal
analyses were repeated in a Bayesian framework allowing for error
in the prediction equations, associations remained similar. More-
over, we have shown that these models fitted our follow-up data
reasonably well (adjusted R2 0.55-0.86) and performed soundly in
a cross-validation exercise (7).
In summary, South Asians and African Caribbeans had greater over-
all truncal adiposity, and South Asian men greater estimated VAT,
than Europeans. Accounting for overall adiposity, estimated VAT
was the strongest correlate of incident diabetes in most groups,
although truncal fat showed the strongest associations in South
Asian women. Associations were generally not explained by differ-
ences in cardiometabolic risk factors or insulin resistance. Further
work should focus on defining the characteristics of upper and lower
body fat in these groups, and exploring reasons for their expansion
and adverse cardiometabolic effects.O
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